Table 3– Tumour response by site among patients harbouring EGFR mutations
PatientDisease sitesPrior WBRT
Brain metastasesPrimary tumourExtracranial metastases
1CRPRCRNo
2PRPRNo ECMYes
3SDPRPRNo
4CRPRCRNo
5CRPRNo ECMNo
6SDPRPRNo
7PRPRPRYes
8CRPRPRYes
9CRPRNo ECMNo
10PRCRPRNo
11CRPRNEYes
12PRCRCRYes
13PRsdNo ECMYes
14CRCRNo ECMYes
15PRPRNo ECMNo
16SDSDNo ECMYes
17CRPRCRYes
  • Data of response to treatment of the primary lung tumour, brain metastasis and extracranial metastases are shown. Whole brain radiotherapy (WBRT) is listed for each patient. EGFR: epidermal growth factor receptor; CR: complete response; PR: partial response; NE: not evaluable; SD: stable disease; ECM: extracranial metastases.